Point Out Statins' CV Benefits STILL Outweigh Diabetes Risk

You'll hear more about higher doses of statins increasing diabetes risk...partly due to reports of lawsuits in the lay press.

Help put this into perspective for patients.

Explain that statins' CV benefits STILL outweigh diabetes risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote